Silence Therapeutics PLC
Biotechnology
Healthcare
SLN
47.23 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.06
52 week high
19.65
high
5.30
52 week low
0.00
previous Close
5.04
P/E ratio
market cap
261 M
div yield
0
net profit margin
0.00 %
20091.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top